These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 453610)

  • 1. Dose-response and plasma concentration-response relationships of pancuronium in man.
    Shanks CA; Somogyi AA; Triggs EJ
    Anesthesiology; 1979 Aug; 51(2):111-8. PubMed ID: 453610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma concentrations of pancuronium and neuromuscular blockade after injection into the isolated arm, bolus injection, and continuous infusion.
    Agoston S; Feldman SA; Miller RD
    Anesthesiology; 1979 Aug; 51(2):119-22. PubMed ID: 453611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma concentrations of pancuronium during predetermined intensities of neuromuscular blockade.
    Shanks CA; Somogyi AA; Triggs EJ
    Br J Anaesth; 1978 Mar; 50(3):235-9. PubMed ID: 637996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship of the serum concentration of pancuronium to its neuromuscular activity in man.
    Agoston S; Crul JF; Kersten UW; Scaf AH
    Anesthesiology; 1977 Dec; 47(6):509-12. PubMed ID: 337856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuromuscular blocking effects of atracurium, vecuronium and pancuronium during bolus and infusion administration.
    Gramstad L; Lilleaasen P
    Br J Anaesth; 1985 Nov; 57(11):1052-9. PubMed ID: 2864943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical pharmacokinetics of pancuronium bromide.
    Somogyi AA; Shanks CA; Triggs EJ
    Eur J Clin Pharmacol; 1976 Sep; 10(5):367-72. PubMed ID: 789085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic and pharmacodynamic modelling with pancuronium.
    Evans MA; Shanks CA; Brown KF; Triggs EJ
    Eur J Clin Pharmacol; 1984; 26(2):243-50. PubMed ID: 6723764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paralysis in the critically ill: intermittent bolus pancuronium compared with continuous infusion.
    de Lemos JM; Carr RR; Shalansky KF; Bevan DR; Ronco JJ
    Crit Care Med; 1999 Dec; 27(12):2648-55. PubMed ID: 10628604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose-response relationships and neuromuscular blocking effects of vecuronium pancuronium during ketamine anaesthesia.
    Engbaek J; Ording H; Pedersen T; Viby-Mogensen J
    Br J Anaesth; 1984 Sep; 56(9):953-7. PubMed ID: 6147154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of pancuronium in man: a linear system.
    Duvaldestin P; Demetriou M; D'Hollander A
    Eur J Clin Pharmacol; 1982 Oct; 23(4):369-72. PubMed ID: 7173308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative pharmacokinetics and dynamics of vecuronium and pancuronium in anesthetized patients.
    Sohn YJ; Bencini AF; Scaf AH; Kersten UW; Agoston S
    Anesth Analg; 1986 Mar; 65(3):233-9. PubMed ID: 2869721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variations in pancuronium requirement, plasma concentration, and urinary excretion induced by cardiopulmonary bypass with hypothermia.
    d'Hollander AA; Duvaldestin P; Henzel D; Nevelsteen M; Bomblet JP
    Anesthesiology; 1983 Jun; 58(6):505-9. PubMed ID: 6859580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison between the continuous infusion of vecuronium and the intermittent administration of pancuronium and vecuronium.
    Noeldge G; Hinsken H; Buzello W
    Br J Anaesth; 1984 May; 56(5):473-7. PubMed ID: 6144316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose-response curves for alcuronium and pancuronium alone and in combination.
    Shanks CA
    Anaesth Intensive Care; 1982 Aug; 10(3):248-51. PubMed ID: 7125191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolonged paralysis after long-term, high-dose infusion of pancuronium in anaesthetized cats.
    Henning RH; Houwertjes MC; Scaf AH; den Hertog A; Agoston S
    Br J Anaesth; 1993 Sep; 71(3):393-7. PubMed ID: 8398522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose-response relation for atracurium, ORG NC 45 and pancuronium.
    Gramstad L; Lilleaasen P
    Br J Anaesth; 1982 Jun; 54(6):647-51. PubMed ID: 6123339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pancuronium requirements during hypothermic cardiopulmonary bypass in man.
    Futter ME; Whalley DG; Wynands JE; Bevan DR
    Anaesth Intensive Care; 1983 Aug; 11(3):216-9. PubMed ID: 6614430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simulating the time-course of clinical paralysis.
    Shanks CA
    Int J Clin Monit Comput; 1988; 5(4):201-5. PubMed ID: 2907346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of large dose of vecuronium with pancuronium for prolonged neuromuscular blockade.
    Rørvik K; Husby P; Gramstad L; Vamnes JS; Bitsch-Larsen L; Koller ME
    Br J Anaesth; 1988 Aug; 61(2):180-5. PubMed ID: 2901270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disuse atrophy with resistance to pancuronium.
    Gronert GA
    Anesthesiology; 1981 Nov; 55(5):547-9. PubMed ID: 7294410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.